Literature DB >> 10413020

Neurodegeneration in hereditary nucleotide repair disorders.

M Itoh1, M Hayashi, K Shioda, M Minagawa, F Isa, K Tamagawa, Y Morimatsu, M Oda.   

Abstract

Both xeroderma pigmentosum group A (XPA) and Cockayne syndrome (CS) are rare autosomal disorders, have a genetic defect in the step of nucleotide repair, and involve various neurological abnormalities caused by progressive neurodegeneration. We performed comprehensive neuropathological analysis of five cases of XPA and four cases of CS. The XPA cases showed widespread neuronal loss throughout the central nervous system, in sharp contrast to the comparative preservation of neurons in the CS cases, who rather exhibited patchy demyelination in the cerebral and cerebellar white matter, and multifocal calcium deposition in the basal ganglia and cerebral white matter, respectively. Exceptionally in the cerebellar cortex, neuronal loss was more severe in CS than in XPA. Grumose or foamy spheroid bodies occurred in the globus pallidus and substantia nigra, and axonal torpedoes were increased in the cerebellar cortex in both disorders. Neither silver impregnation nor immunohistochemistry for ubiquitin or tau succeeded in visualizing neurofibrillary tangles, senile plaques or augmented ubiquitination in either disorder, and these findings did not support the involvement of facilitated aging in the neurodegeneration in XPA or CS.

Entities:  

Mesh:

Year:  1999        PMID: 10413020     DOI: 10.1016/s0387-7604(99)00033-9

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  25 in total

1.  DNA repair on the brain.

Authors:  R R Laposa; J E Cleaver
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

Review 2.  Cockayne syndrome group B cellular and biochemical functions.

Authors:  Cecilie Löe Licht; Tinna Stevnsner; Vilhelm A Bohr
Journal:  Am J Hum Genet       Date:  2003-11-24       Impact factor: 11.025

3.  Cockayne syndrome B protects against methamphetamine-enhanced oxidative DNA damage in murine fetal brain and postnatal neurodevelopmental deficits.

Authors:  Gordon P McCallum; Andrea W Wong; Peter G Wells
Journal:  Antioxid Redox Signal       Date:  2011-01-05       Impact factor: 8.401

4.  Neuroimaging in Cockayne syndrome.

Authors:  M Koob; V Laugel; M Durand; H Fothergill; C Dalloz; F Sauvanaud; H Dollfus; I J Namer; J-L Dietemann
Journal:  AJNR Am J Neuroradiol       Date:  2010-06-03       Impact factor: 3.825

Review 5.  Cockayne syndrome: Clinical features, model systems and pathways.

Authors:  Ajoy C Karikkineth; Morten Scheibye-Knudsen; Elayne Fivenson; Deborah L Croteau; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2016-08-06       Impact factor: 10.895

6.  Cockayne syndrome: a diffusion tensor imaging and volumetric study.

Authors:  Mériam Koob; François Rousseau; Vincent Laugel; Nicolas Meyer; Jean-Paul Armspach; Nadine Girard; Jean-Louis Dietemann
Journal:  Br J Radiol       Date:  2016-09-19       Impact factor: 3.039

Review 7.  The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.

Authors:  P J Brooks
Journal:  Neuroscience       Date:  2006-12-19       Impact factor: 3.590

Review 8.  DNA repair deficiency and neurological disease.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2009-01-15       Impact factor: 34.870

9.  On the traces of XPD: cell cycle matters - untangling the genotype-phenotype relationship of XPD mutations.

Authors:  Elisabetta Cameroni; Karin Stettler; Beat Suter
Journal:  Cell Div       Date:  2010-09-15       Impact factor: 5.130

10.  Blinded by the UV light: how the focus on transcription-coupled NER has distracted from understanding the mechanisms of Cockayne syndrome neurologic disease.

Authors:  P J Brooks
Journal:  DNA Repair (Amst)       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.